Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:40 PM
Ignite Modification Date:
2025-12-24 @ 5:40 PM
NCT ID:
NCT02843568
Eligibility Criteria:
Inclusion Criteria:
* Histologic diagnosis of non-small cell lung cancer or lung metastasis from a solid tumor. One biopsy site is adequate for multiple sites of thoracic disease.
* Treatment includes localized radiation therapy with or without chemotherapy
* Karnofsky ≥ 60%
* Not pregnant per radiation oncology standard procedures
* Ability to understand and the willingness to sign a written informed consent document
Exclusion Criteria:
* Prior (within last 6 months) or future planned therapeutic surgery for the treatment of the existing lung cancer
* Prior thoracic radiotherapy
* Severe COPD defined as disease requiring an inpatient stay for respiratory deterioration within the past 3 months
* Oxygen dependence of \> 2 L/min continuously throughout the day at baseline
* Known underlying collagen vascular disease or intrinsic lung disease that could complicate expected sequelae of radiation (idiopathic pulmonary fibrosis, Wegener's granulomatosis)
* Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02843568
Study Brief:
Protocol Section:
NCT02843568